Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RWReeves who wrote (1394)	3/3/2000 11:50:00 AM
From: Jibacoa	Read Replies (1) of 2344

<<<Compared to the immunotherapeutics pipeline at IMMU, BIOM seems pretty fully priced.>>> I think BIOM has pretty good products on its pipeline and with very good probability of FDA approval in not too distant future. If you want to compare it with other "biotechs" take a look at some of the ones that have been on the lime light lately like ARIA which has been very "hot" in the past 2 weeks and had a CC yesterday and an interview in TV today. Their products are still on phase I in trials with mice. They won't have a product in the market for at least 5 yrs. One that has a good amount of products on its pipeline and good "partners" including Roche is VLTS. If you are long BIOM and would like to sell it I don't think you would be suggesting others that you think have a "better pipeline". If you want to short BIOM please go ahead and do it. Me, I just will keep buying it on any dips. Have a good day. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next